LATISSE® is an FDA-approved
This product is currently sold out.
LATISSE® (bimatoprost ophthalmic solution) 0.03% Important Information
LATISSE® is an FDA-approved treatment to grow eyelashes for people with inadequate or not enough lashes.
Latisse® (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or sparse eyelashes – lashes grow longer, fuller and darker with Latisse®. Latisse is manufactured and backed by the global leader in pharmaceuticals, Allergan.
"needs a valid prescription required"